Trimethylamine N-Oxide Exacerbates Renal Inflammation and Fibrosis in Rats With Diabetic Kidney Disease
The gut microbiota plays a pivotal role in the onset and development of diabetes and its complications. Trimethylamine N-oxide (TMAO), a gut microbiota-dependent metabolite of certain nutrients, is associated with type 2 diabetes and its complications. Diabetic kidney disease (DKD) is one of the mos...
Main Authors: | Qing Fang, Binjie Zheng, Na Liu, Jinfeng Liu, Wenhui Liu, Xinyi Huang, Xiangchang Zeng, Lulu Chen, Zhenyu Li, Dongsheng Ouyang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-06-01
|
Series: | Frontiers in Physiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphys.2021.682482/full |
Similar Items
-
TMAO as a potential biomarker and therapeutic target for chronic kidney disease: A review
by: Ye Zixin, et al.
Published: (2022-08-01) -
The Immunological Mechanisms and Immune-Based Biomarkers of Drug-Induced Liver Injury
by: Wenhui Liu, et al.
Published: (2021-10-01) -
Gut Microbiota Modulates the Protective Role of Ginsenoside Compound K Against Sodium Valproate-Induced Hepatotoxicity in Rat
by: Luping Zhou, et al.
Published: (2022-07-01) -
Ginsenoside compound K attenuates cognitive deficits in vascular dementia rats by reducing the Aβ deposition
by: Wenjing Zong, et al.
Published: (2019-03-01) -
Hsa_circ_0037128 aggravates high glucose-induced podocytes injury in diabetic nephropathy through mediating miR-31-5p/KLF9
by: Rong Fang, et al.
Published: (2022-05-01)